The contribution of rapid intraoperative cytology in the evaluation of endometrial cancer spread.

INTRODUCTION Peritoneal washing cytology and imprint cytology of pelvic lymph nodes samples were used to evaluate the rapid cytologic detection of peritoneal and retroperitoneal spread of endometrial cancer. MATERIALS AND METHODS We undertook a study on 194 endometrial cancer patients who underwent primary treatment in the Gynecologic Clinic, Democritus University of Thrace. All patients were subjected to peritoneal washing (PW) cytology and imprint cytology performed on lymph node sampling. The cytologic specimens were stained by May-Grünwald Giemsa (MGG) and Haematoxylin eosin (HE) techniques. Cell-blocks prepared from peritoneal washings (PWs) and the lymph node samples were sent for histologic examination. The cytologic fi ndings were correlated to histologic results. RESULTS Rapid intraoperative cytology provides a useful diagnostic technique for the assessment of endometrial cancer spread. HE and MGG stain presented different values of sensitivity and specifi city in the detection of peritoneal and retroperitoneal spread of endometrial cancer. CONCLUSION Cytologic assessment of intraperitoneal and retroperitoneal spread of endometrial cancer is a rapid, intraoperative procedure, which provides the surgeon with useful information regarding the stage of the disease and the subsequent therapeutic approach.

[1]  J. Thigpen.  The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer , 2008 .

[2]  N. Yaegashi,et al.  Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer. , 2007, Gynecologic oncology.

[3]  A. Berchuck,et al.  The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. , 2007, Gynecologic oncology.

[4]  A. Berchuck,et al.  Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology , 2006 .

[5]  H. Watari,et al.  Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. , 2005, Gynecologic oncology.

[6]  M. Mlynček,et al.  Peritoneal cytology in endometrial cancer. , 2005, Neoplasma.

[7]  F. Wong,et al.  Treatment results of endometrial carcinoma with positive peritoneal washing, adnexal involvement and serosal involvement. , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

[8]  R. Zellars,et al.  FIGO stage IIIC endometrial carcinoma: Resection of macroscopic nodal disease and other determinants of survival , 2003, International Journal of Gynecologic Cancer.

[9]  M. J. Webb,et al.  Assessment of prognostic factors in stage IIIA endometrial cancer. , 2002, Gynecologic oncology.

[10]  M. Gu,et al.  Peritoneal Washings in Endometrial Carcinoma , 2000, Acta Cytologica.

[11]  H. Yun,et al.  Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. , 1998, Gynecologic oncology.

[12]  M. Inbar,et al.  The role of routine pelvic lymph node sampling in patients with stage I endometrial carcinoma, second thoughts , 1998, Acta obstetricia et gynecologica Scandinavica.

[13]  M. Janicek,et al.  Significance of intraperitoneal cytology in patients undergoing radical hysterectomy. , 1998, Gynecologic oncology.

[14]  T. Kaku,et al.  The significance of peritoneal cytology in uterine cervix and endometrial cancer. , 1997, Gynecologic oncology.

[15]  Y. Erozan,et al.  Significance of peritoneal washings in gynecologic oncology. The experience with 901 intraoperative washings at an academic medical center. , 1997, Archives of pathology & laboratory medicine.

[16]  Y. Hirai,et al.  Pelvic Lymph Node Metastasis in Endometrial Cancer With No Myometrial Invasion , 1996, Obstetrics and gynecology.

[17]  A. Behrens,et al.  Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients. , 1996, Journal of the National Cancer Institute.

[18]  G. Tortolero-Luna,et al.  Staging laparotomy for endometrial carcinoma: assessment of peritoneal spread. , 1995, Gynecologic oncology.

[19]  C. Morrow,et al.  Relationship between surgical‐pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study , 1991, Gynecologic oncology.

[20]  A. Rademaker,et al.  Prognostic Factors Associated With Recurrence in Clinical Stage I Adenocarcinoma of the Endometrium , 1991, Obstetrics and gynecology.

[21]  M. Wade,et al.  Adenocarcinoma of the endometrium. , 1967, American journal of obstetrics and gynecology.

[22]  L. CruzRamirez,et al.  Adenocarcinoma of the endometrium , 1959 .

[23]  K. Zieliński,et al.  Announcements , 1974, Nature.